Evidence map›Paper›PMID 22923473›Full record

ArticleDiabetes2013

Liver glycogen loading dampens glycogen synthesis seen in response to either hyperinsulinemia or intraportal glucose infusion.

Jason J Winnick, Zhibo An, Guillaume Kraft, Christopher J Ramnanan, Jose M Irimia, Marta Smith, Margaret Lautz, Peter J Roach, Alan D Cherrington

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia.American journal of physiology. Endocrinology and metabolism · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jason J WinnickDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. jason.winnick@vanderbilt.edu
Zhibo An
Guillaume Kraft
Christopher J Ramnanan
Jose M Irimia
Marta Smith
Margaret Lautz
Peter J Roach
Alan D Cherrington
Vanderbilt University · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
GLUCONEOGENESIS &GLYCOGENOLYSIS:ROLE &REGULATIONR01DK018243 · NIDDK · VANDERBILT UNIVERSITY · PI Alan D Cherrington, Dale S Edgerton · 1986 to 2026
$12.2M
HORMONAL CONTROL OF GLYCOGEN METABOLISMR37DK027221 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ROACH, PETER J · 1992 to 2014
$5.2M
REGULATION OF NET HEPATIC GLUCOSE UPTAKE IN VIVOR01DK043706 · NIDDK · VANDERBILT UNIVERSITY · PI CHERRINGTON, ALAN D · 1991 to 2009
$4.6M
Effect of hepatic glycogen level on hepatic glucose uptake and dispositionF32DK080606 · NIDDK · VANDERBILT UNIVERSITY · PI WINNICK, JASON · 2007 to 2009
$96k
NIDDK NIH HHS DK-20593NIDDK NIH HHS F32 DK080606NIDDK NIH HHS F32-DK-080606NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK018243NIDDK NIH HHS R01 DK043706NIDDK NIH HHS R01-DK-43706NIDDK NIH HHS R37 DK027221NIDDK NIH HHS T32 DK007563
6 · The paper itself

Abstract

The purpose of this study was to determine the effect of liver glycogen loading on net hepatic glycogen synthesis during hyperinsulinemia or hepatic portal vein glucose infusion in vivo. Liver glycogen levels were supercompensated (SCGly) in two groups (using intraportal fructose infusion) but not in two others (Gly) during hyperglycemic-normoinsulinemia. Following a 2-h control period during which fructose infusion was stopped, there was a 2-h experimental period in which the response to hyperglycemia plus either 4× basal insulin (INS) or portal vein glucose infusion (PoG) was measured. Increased hepatic glycogen reduced the percent of glucose taken up by the liver that was deposited in glycogen (74 ± 3 vs. 53 ± 5% in Gly+INS and SCGly+INS, respectively, and 72 ± 3 vs. 50 ± 6% in Gly+PoG and SCGly+PoG, respectively). The reduction in liver glycogen synthesis in SCGly+INS was accompanied by a decrease in both insulin signaling and an increase in AMPK activation, whereas only the latter was observed in SCGly+PoG. These data indicate that liver glycogen loading impairs glycogen synthesis regardless of the signal used to stimulate it.

Indexed as

AMP-Activated Protein KinasesAnimalsDogsGlucoseHyperinsulinismLiverLiver GlycogenPortal VeinAMP-Activated Protein KinasesGlucoseLiver Glycogen

Identifiers

PMID22923473
PMCPMC3526057
OpenAlexW2162303959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.